You just read:

Blueprint Medicines Presents NAVIGATOR Trial Data in PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST at ASCO 2019 Supporting Planned Marketing Applications for Avapritinib

News provided by

Blueprint Medicines Corporation

Jun 01, 2019, 09:00 ET